LOINC Result Terms Value set¶
| Canonical | https://fhir.apps.health/ValueSet/nexus-loinc-result |
|---|---|
| Status | draft · 1.33.0 |
| Source | FSH · JSON |
Every LOINC term that can code a reported result, for Observation.code: the terms whose ORDER_OBS
property is Observation, Both or Subset, excluding the LOINC Document Ontology, claims
attachments and deprecated terms.
What is in, and why. Observation and Both terms are reported. Subset terms are in because
the members of a panel are reported as results even where the panel is only ordered. Surveys
(CLASSTYPE 4) are in: a scored instrument such as a depression or anxiety screen is recorded as an
Observation, and its score is a result. Report-level terms such as imaging reports are in, because
they are what a result report is coded with.
What is out, and why. The LOINC Document Ontology is out: a clinical document kind is not a
result (it is matched by CLASS = LP32519-8, the Part for the Document Ontology class). Claims
attachments (CLASSTYPE 3) are out: they qualify an attachment sent with a claim. Terms with no
ORDER_OBS value are not members.
Laboratory results in Canada. The pan-Canadian LOINC Observation Code Database, served under
https://fhir.infoway-inforoute.ca/CodeSystem/pCLOCD, is the Canadian subset for laboratory results
(see pan-Canadian LOINC Properties). This set is not limited to it,
because results also include vital signs and clinical observations.
Defined, not enumerated. The set is a filter on LOINC's own properties, so its membership follows
the LOINC release the terminology service holds and needs no release of this guide. It carries no
expansion; $expand it against the terminology service.
Definition¶
Includes
- Codes from LOINC where
ORDER_OBSisObservation,BothorSubset
Excludes
- Codes from LOINC where
CLASSisLP32519-8 - Codes from LOINC where
CLASSTYPEis3 - Codes from LOINC where
STATUSisDEPRECATED
Codes¶
This set has 85,065 codes, as the terminology service expands it. 500 are shown below, spread evenly across the code range; this page is not the expansion.
Displays from version 2.83.
The sample is drawn from the 80,960 of them that may be reproduced here; 4,105 carrying a third-party copyright notice are counted but not shown.
Attribution required by the publisher
This material contains content from LOINC (https://loinc.org). LOINC is copyright (c) 1995+ Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the LOINC licence (https://loinc.org/license). LOINC(R) is a registered United States trademark of Regenstrief Institute, Inc. Terms carrying a third-party copyright notice are not reproduced here.
| Code | Display |
|---|---|
1-8 |
Acyclovir [Susceptibility] |
100162-7 |
Knee alignment W standing X-ray measured |
100334-2 |
Been physically hurt with some degree of injury |
100686-5 |
JC virus DNA [Log #/volume] (viral load) in Cerebrospinal Fluid by NAA with probe detection |
100862-2 |
Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
101089-1 |
Ge3 Ag [Presence] on Red Blood Cells |
101252-5 |
Urea [Mass/volume] in Dialysis fluid |
101420-8 |
Human coronavirus HKU1 RNA [Presence] in Respiratory system specimen by NAA with probe detection |
101588-2 |
Histoplasma capsulatum+Blastomyces dermatitidis Ag [Presence] in Serum or Plasma by Immunoassay |
101774-8 |
Microsporum ferrugineum DNA [Presence] in Specimen by NAA with probe detection |
101993-4 |
Kynurenate/Creatinine [Mass Ratio] in Urine |
102186-4 |
Blueberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
102340-7 |
Kentucky blue grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
102486-8 |
Papaya (Carica papaya) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
102647-5 |
Walnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
102807-5 |
Rice IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
102968-5 |
Trichophyton sp IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
103127-7 |
Honey bee recombinant (rApi m) 10 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) |
103297-8 |
XR Cervical spine GE 3 Views |
103442-0 |
XR Wrist - right and Hand - right GE 3 Views |
103619-3 |
Coagulation surface induced.lupus sensitive.buffer (LA control) in Platelet poor plasma by Coagulation assay |
103832-2 |
Naloxone [Presence] in Meconium |
1040-5 |
G Ag [Presence] on Red Blood Cells from Donor |
104192-0 |
Guanidinoacetate methyltransferase deficiency newborn screen interpretation |
10435-6 |
C5B-9 Ag [Presence] in Tissue by Immune stain |
104521-0 |
T little c super little c Ab [Presence] in Serum or Plasma |
104735-6 |
Influenza virus B RNA [Presence] in Specimen by Molgen |
104891-7 |
Communication aid Person Narrative |
105047-5 |
Clostridioides difficile presence and susceptibility in Specimen Document by Organism specific culture |
10522-1 |
Coagulation factor XIII Ag [Presence] in Tissue by Immune stain |
105521-9 |
Breastfeeding start date |
105694-4 |
Nakaseomyces nivariensis DNA [Presence] in Specimen by NAA with probe detection |
105880-9 |
Cytomegalovirus DNA [Units/volume] in Serum or Plasma |
10603-9 |
Spermatozoa Abnormal Midpiece/Spermatozoa in Semen |
106289-2 |
US Guidance for injection of Tendon |
106460-9 |
How much suffering do you experience because of your pain |
106627-3 |
Width palpebral fissure opening [Length] in Eye from Fetus |
106795-8 |
Ganglioside GT1a IgM Ab [Presence] in Serum by Immunoassay |
106975-6 |
Dihydroboldenone [Presence] in Urine by Gas chromatography-mass spectrometry |
107164-6 |
Weight [Mass] Kidney - bilateral |
107337-8 |
Amikacin [Susceptibility] liposome inhaled breakpoints by Minimum inhibitory concentration (MIC) |
107516-7 |
N-Desethyl Isotonitazene [Mass/volume] in Urine by Confirmatory method |
107702-3 |
Lamb meat IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
107854-2 |
Cayenne IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
108068-8 |
Amaranth IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
108233-8 |
Social network note |
10945-4 |
Papain IgE Ab [Units/volume] in Serum |
11094-0 |
Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma |
111589-8 |
Left eye Performed Protocol Pattern [Units/mass] Static Automated Perimetry |
111748-0 |
Wind velocity |
111903-1 |
Number of approaches to papilla until deep cannulation Biliary duct and Pancreatic duct Endoscopy |
112049-2 |
Endoscopic procedure Minor papilla Endoscopy |
112209-2 |
Red mulberry IgE Ab [Units/volume] in Serum or Plasma by Immunoassay |
112452-8 |
Did a parent or adult in your home ever swear at you, insult you, or put you down |
112612-7 |
Expanded Food Security Screener Priority Level [FSS-Exp] |
112786-9 |
Platelet aggregation in Platelet rich plasma by Aggregometry.adenosine diphosphate induced.1.0 umol/L |
112953-5 |
Walnut (Juglans regia recombinant) rJug r 4 IgE Ab [Units/volume] in Serum or Plasma by Immunoassay |
113186-1 |
Flualprazolam/Creatinine [Mass Ratio] in Urine |
113350-3 |
JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine |
113516-9 |
Tricyclic antidepressants [Presence] in Urine by Immunoassay>300 ng/mL |
113677-9 |
oxyCODONE [Mass/volume] in Saliva (oral fluid) by Mass Spectrometry |
113837-9 |
Methadone [Presence] in Blood by Immunoassay |
113998-9 |
HYDROcodone [Presence] in Saliva (oral fluid) by Mass Spectrometry |
114156-3 |
chlordiazePOXIDE [Presence] in Urine by Immunoassay |
114316-3 |
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Body fluid by Immunoassay |
114513-5 |
Western equine encephalitis virus RNA [Presence] in Specimen by Molgen |
114673-7 |
Rotavirus C RNA [Presence] in Specimen by Molgen |
114821-2 |
Mycobacterium sp DNA [Presence] in Specimen by Molgen |
114980-6 |
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Specimen by Molgen |
115139-8 |
Enterobacter hormaechei DNA [Presence] in Specimen by Molgen |
115288-3 |
Candida auris ITS2 gene [Presence] in Specimen by Molgen |
115446-7 |
Adenovirus 3+4+7+21 DNA [Presence] in Specimen by Molgen |
115768-4 |
Posaconazole --trough [Mass/volume] of Serum |
11702-8 |
Cerebral artery middle Peak systolic flow velocity US.doppler |
11863-8 |
Fetal Cerebellum Diameter transverse US |
12019-6 |
Fetal Umbilical artery at placenta Resistivity index US.doppler |
12170-7 |
Fetal Head Hemisphere width US |
12328-1 |
Beta blockers [Identifier] in Urine |
12487-5 |
Butalbital [Presence] in Gastric fluid |
12636-7 |
Glucose [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
12793-6 |
Oxalate [Mass/volume] in Urine --5th specimen post XXX challenge |
12948-6 |
Thyrotropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
1316-9 |
S Ab [Presence] in Serum or Plasma from Donor |
13318-1 |
Escherichia coli enteroinvasive identified in Stool by Organism specific culture |
13471-8 |
Cadmium/Creatinine [Mass Ratio] in Urine |
13627-5 |
Erythrocytes [Presence] in Semen by Light microscopy |
13778-6 |
Mevalonate/Creatinine [Mass Ratio] in Urine |
13933-7 |
Benzodiazepines [Mass/mass] in Hair |
14084-8 |
Herpes simplex virus 1 [Presence] in Isolate by Immunofluorescence |
14238-0 |
Myelin basic protein IgG Ab [Units/volume] in Serum |
14390-9 |
Amylase [Enzymatic activity/volume] in Dialysis fluid |
14542-5 |
Measles virus Ag [Presence] in Urine sediment by Immunofluorescence |
14693-6 |
Norclobazam [Moles/volume] in Serum or Plasma |
1484-5 |
Gastrin [Mass/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin |
14989-8 |
little i-2 subtype [Presence] on Red Blood Cells from Blood product unit |
1514-9 |
Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
15292-6 |
Testis - left Height by US |
15443-5 |
Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
16129-9 |
Hepatitis C virus IgG Ab [Presence] in Serum |
16279-2 |
Toxoplasma gondii DNA [Presence] in Blood by NAA with probe detection |
16451-7 |
Beryllium [Presence] in Urine |
16609-0 |
Chlorphentermine [Units/volume] in Blood |
16765-0 |
Dichlorodiphenyltrichloroethane [Mass/volume] in Milk |
16928-4 |
Hantavirus puumala IgG+IgM Ab [Units/volume] in Serum |
17079-5 |
Fatty acids.long chain [Identifier] in Serum or Plasma |
17229-6 |
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebrospinal Fluid |
1739-2 |
Alanine [Mass/time] in 24 hour Urine |
1754-1 |
Albumin [Mass/volume] in Urine |
17727-9 |
Treponema pallidum IgG Ab [Units/volume] in Serum by Immunofluorescence |
17878-0 |
Bacteria # 2 identified in Bronchial specimen by Aerobe culture |
18025-7 |
Heart Diameter anterior-posterior systole/Aortic root diameter by US |
18173-5 |
Pulmonary artery Blood velocity-time integral by US.doppler |
18333-5 |
Echovirus 7 Ab [Units/volume] in Cerebrospinal Fluid |
18483-8 |
Yeast [Presence] in Genital specimen by Organism specific culture |
18860-7 |
Amikacin [Susceptibility] |
19023-1 |
Granulocytes/Leukocytes in Blood by Automated count |
19233-6 |
Bicarbonate [Moles/volume] standard in Mixed venous blood |
19391-2 |
Chlorpheniramine [Mass/volume] in Urine by Confirmatory method |
19557-8 |
Methamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
19732-7 |
Cat serum albumin IgE Ab [Units/volume] in Serum |
20189-7 |
Ventricular Cardiac index by US.cubed.calculated |
20341-4 |
Time/Time 2 by US |
20493-3 |
Histiocytes/cells in Body fluid by Light microscopy |
20655-7 |
Proline [Moles/volume] in Serum or Plasma |
20809-0 |
Ergot alkaloid [Mass/mass] in Feed |
20964-3 |
Shigella sp identified in Feed by Organism specific culture |
2116-2 |
Choriogonadotropin.intact [Presence] in Serum or Plasma |
2137-8 |
Coproporphyrin [Mass/time] in 24 hour Urine |
21592-1 |
Varicella zoster virus Ab [Titer] in Cerebrospinal Fluid |
21759-6 |
FMR1 gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
22120-0 |
Borrelia burgdorferi Ab [Units/volume] in Body fluid |
22271-1 |
Echovirus 16 Ab [Titer] in Serum |
22426-1 |
Mycoplasma pneumoniae IgG Ab [Titer] in Serum |
22603-5 |
Varicella zoster virus IgG Ab [Units/volume] in Serum --1st specimen |
22767-8 |
African horse sickness virus Ab [Presence] in Serum by Immunoblot |
22916-1 |
Bovine leukemia virus Ab [Presence] in Milk by Immunoassay |
23067-2 |
Epizootic hemorrhagic disease virus RNA [Presence] in Blood by NAA with probe detection |
23212-4 |
Lumpy skin disease virus [Presence] in Tissue by Electron microscopy |
23364-3 |
Porcine enterovirus Ag [Presence] in Specimen by Immunofluorescence |
23520-0 |
Trypanosoma evansi [Presence] in Aspirate by Wet preparation |
23683-6 |
Brucella canis Ab [Titer] in Serum by Immunofluorescence |
23836-0 |
Carbon disulfide [Mass/volume] in Serum or Plasma |
24001-0 |
Ganglioside GQ1b IgG Ab [Titer] in Cerebrospinal Fluid by Immunoassay |
24171-1 |
Polio virus 2 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
24381-6 |
Platelet aggregation interpretation in Platelet rich plasma Qualitative Induced by Arachidonate |
24541-5 |
XR Ankle Views |
24698-3 |
RFA Guidance for angioplasty of Femoral artery-- W contrast IA |
24867-4 |
MR Pelvis |
25034-0 |
RF Wrist Arthrogram |
25190-0 |
Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 8.0 ug/mL |
25364-1 |
Campylobacter jejuni Ab [Titer] in Serum by Complement fixation |
25538-0 |
Thermoactinomyces vulgaris IgG Ab [Units/volume] in Serum |
25712-1 |
Leptospira interrogans sv Pomona Ab [Titer] in Serum by Complement fixation |
25877-2 |
Citrulline [Moles/volume] in 24 hour Urine |
26029-9 |
Lactoferrin bovine IgE Ab [Units/volume] in Serum |
2619-5 |
Methemoglobin [Presence] in Red Blood Cells |
26338-4 |
MG Guidance for biopsy of Breast - left |
26511-6 |
Neutrophils/Leukocytes in Blood |
26664-3 |
Chlamydia trachomatis E Ab [Presence] in Serum |
26815-1 |
Cocaethylene [Mass/mass] in Meconium |
26968-8 |
Beta alanine [Moles/volume] in Urine |
27120-5 |
Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum --2nd specimen |
27291-4 |
Hydroxylysine [Moles/volume] in Urine |
2757-3 |
Phenol [Mass/volume] in Blood |
27939-8 |
Collagen crosslinked N-telopeptide [Moles/volume] in Urine |
2825-8 |
Potassium [Moles/volume] in Saliva (oral fluid) |
28926-4 |
Right contact lens prescription Explanation [Interpretation] |
29282-1 |
Glutethimide [Presence] in Gastric fluid |
29447-0 |
Left ventricular posterior wall Thickening.fractional change by US.M-mode |
29624-4 |
3-Hydroxyglutarate [Presence] in Urine |
29777-0 |
Coxiella burnetii phase 2 IgG Ab [Presence] in Serum by Immunoassay |
29926-3 |
Boron [Mass/volume] in 24 hour Urine |
30074-9 |
Hemoglobin F [Presence] in Specimen |
30222-4 |
Coxsackievirus B3 Ab [Presence] in Serum |
30375-0 |
Basophils/Leukocytes in Sputum |
30536-7 |
Magnesium [Mass/volume] in Total parental nutrition |
30690-2 |
MR Upper arm WO and W contrast IV |
30846-0 |
RFA Renal vein - bilateral Views W contrast IV |
310-3 |
Lymecycline [Susceptibility] by Minimum lethal concentration (MLC) |
31150-6 |
ERBB2 gene duplication [Presence] in Tissue by FISH |
31302-3 |
Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum |
31461-7 |
Legionella pneumophila 4 Ab [Units/volume] in Serum |
31611-7 |
Rickettsia typhi IgM Ab [Units/volume] in Body fluid |
31780-0 |
Chlamydophila psittaci Ag [Presence] in Specimen |
31929-3 |
Parainfluenza virus Ag [Presence] in Specimen |
32076-2 |
Glutethimide [Moles/volume] in Serum or Plasma |
32221-4 |
Alanine [Moles/volume] in Vitreous fluid |
32372-5 |
Fleroxacin [Susceptibility] |
32603-3 |
Itraconazole [Susceptibility] |
32757-7 |
BCL2 cells/cells in Specimen |
33006-8 |
Cytomegalovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
33157-9 |
Fetal Head Diameter.biparietal/Diameter.occipital estimated from gestational age by method of Chitty 1994 (US) |
3332-4 |
Amitriptyline [Presence] in Serum or Plasma |
33501-8 |
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactose PO |
33657-8 |
Beta-N-acetylhexosaminidase.A [Moles/volume] in Leukocytes |
33813-7 |
Insulin [Units/volume] in Serum or Plasma --14th specimen post XXX challenge |
33963-0 |
Granulocytes/Leukocytes in Cerebrospinal Fluid |
34231-1 |
Aldosterone/Creatinine [Molar ratio] in Urine |
34379-8 |
Teicoplanin [Mass/volume] in Serum or Plasma --trough |
3455-3 |
Chloramphenicol [Mass/volume] in Serum or Plasma |
34717-9 |
Coxiella burnetii phase 2 IgG Ab [Titer] in Serum by Immunofluorescence |
3502-2 |
Clostebol [Presence] in Urine |
35182-5 |
Docosatetraenoate (C22:4w6) [Moles/volume] in Serum or Plasma |
35329-2 |
pH of Body fluid--2nd specimen post Sincalide |
35479-5 |
Diazinon [Mass/volume] in Urine |
35657-6 |
Urea nitrogen/Body weight [Mass/kg/time] in 24 hour Urine |
35818-4 |
Grepafloxacin [Susceptibility] by Disk diffusion (KB) |
35965-3 |
CT Elbow - bilateral |
36110-5 |
CT Lumbar spine limited WO contrast |
36260-8 |
CT Lower leg - left W contrast IV |
3641-8 |
Flunitrazepam [Mass/volume] in Urine |
36560-1 |
XR Femur - left Single view |
36707-8 |
XR Humerus - bilateral AP and Lateral |
36857-1 |
MRA Head vessels WO and W contrast IV |
37015-5 |
XR Abdomen PA prone |
37168-2 |
Portable XR Hip Views |
37384-5 |
RFA Vertebral artery Views W contrast IA |
37549-3 |
XR Wrist - bilateral PA and Lateral and Oblique |
3770-5 |
Metenolone [Mass/time] in 24 hour Urine |
37848-9 |
XR Acromioclavicular Joint Zanca |
38002-2 |
XR Chest Single view W inspiration |
3817-4 |
Metoprolol [Mass/volume] in Urine |
38343-0 |
Chlorobenzene [Mass/volume] in Water |
38496-6 |
Retinyl palmitate [Mass/volume] in Serum or Plasma |
38643-3 |
Calcium cyanamide [Mass/volume] in Air |
3879-4 |
Opiates [Presence] in Urine |
39001-3 |
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma |
39307-4 |
Influenza virus A H6 Ab [Titer] in Serum by Hemagglutination inhibition |
39456-9 |
Acetaminophen [Moles/volume] in Urine |
39604-4 |
Mugwort IgE Ab/IgE total in Serum |
39759-6 |
SPECT Guidance limited for localization of tumor |
39923-8 |
NM Heart Gated and Ejection fraction at rest and W radionuclide IV |
40072-1 |
Calcium [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
40218-0 |
Glucose [Moles/volume] in Serum or Plasma --29 hours post XXX challenge |
40366-7 |
Glucose [Moles/time] in 24 hour Body fluid |
40520-9 |
Macrophages/Leukocytes in Pleural fluid by Manual count |
40677-7 |
Toxoplasma gondii IgG Ab [Presence] in Serum by Immunoassay |
40829-4 |
Ornithine [Presence] in Blood |
40992-0 |
Rhinovirus+Enterovirus Ag [Presence] in Specimen by Immunofluorescence |
41139-7 |
Influenza virus A N4 Ab [Presence] in Serum |
41289-0 |
11-Deoxycortisol [Mass/volume] in Serum or Plasma --post dose metyraPONE |
41475-5 |
Rickettsia rickettsii IgM Ab [Presence] in Serum by Immunoassay |
41704-8 |
Nafcillin [Susceptibility] by Gradient strip |
41864-0 |
Yeast.hyphae [Presence] in Urine by Computer assisted method |
42179-2 |
PLP1 gene duplication [Presence] in Blood or Tissue by Molecular genetics method |
4235-8 |
Enoxacin [Mass] of Dose |
42505-8 |
Hepatitis B virus surface Ag [Presence] in Cerebrospinal Fluid |
42696-5 |
MR Lower leg - bilateral |
42886-2 |
CD52 cells/cells in Bone marrow |
43036-3 |
Feline herpesvirus Ab [Titer] in Serum |
43227-8 |
Ova and parasites identified in Stool by Trichrome stain |
43391-2 |
Bacterial vaginosis score |
43573-5 |
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebrospinal Fluid by Immunoblot |
43731-9 |
Alkaline phosphatase.fetal+lung+lymphocyte [Presence] in Serum or Plasma |
43883-8 |
Ampicillin [Presence] in Serum or Plasma |
4403-2 |
Piperacillin [Mass] of Dose |
44184-0 |
Portable XR Elbow 2 Views |
44348-1 |
Phenylalanine/Creatinine [Mass Ratio] in 24 hour Urine |
44497-6 |
Herpes simplex virus 2 Ag [Presence] in Vaginal fluid |
44657-5 |
Dominant nodule.maximum.dimension in Prostate tumor |
44821-7 |
Leishmania brasilensis IgG Ab [Titer] in Serum by Immunofluorescence |
44979-3 |
Chlamydophila pneumoniae Ab [Presence] in Serum --2nd specimen |
45149-2 |
Ej Ab [Presence] in Serum |
45337-3 |
Bacterial biochemical profile [Identifier] in Isolate by Culture |
45956-0 |
Reason pneumococcal vaccine not received during assessment period [CMS Assessment] |
46261-4 |
HYDROcodone Free [Presence] in Serum or Plasma |
46417-2 |
Prothrombin time (PT) in Capillary blood by Coagulation assay |
46780-3 |
Short-chain acyl-CoA deficiency (SCAD); ethylmalonic encephalopathy; isobutyryl-CoA dehydrogenase deficiency newborn screen interpretation |
47087-2 |
Angiotensinogen [Moles/volume] in Plasma |
47235-7 |
Reagin Ab [Titer] in Specimen by VDRL |
47422-1 |
Aspergillus flavus H Ab [Presence] in Serum |
47591-3 |
C peptide [Moles/volume] in Serum or Plasma --3 minutes post dose glucose |
47738-0 |
Prostate specific Ag [Mass/volume] in Body fluid |
47891-7 |
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose growth hormone releasing factor |
48041-8 |
Anthraquinone cutoff [Mass/mass] in Stool |
48191-1 |
Monosodium glutamate (MSG) triggered leukotriene release [Mass/volume] by Leukocytes |
48341-2 |
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
48491-5 |
XR Temporomandibular joint - left Open and Closed mouth |
48685-2 |
Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 10.0 ug/mL |
48866-8 |
Ehrlichia sp DNA [Presence] in Specimen by NAA with probe detection |
49033-4 |
Menstrual History - Reported |
49192-8 |
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --2nd specimen |
49340-3 |
Adenovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
49487-2 |
Nateglinide [Presence] in Serum or Plasma |
49640-6 |
Protein S Ag/Coagulation factor X Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay |
4980-9 |
HLA-DR3 [Presence] in Donor |
49954-1 |
Somatotropin [Units/volume] in Serum or Plasma --4 AM specimen |
50101-5 |
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Cerebrospinal Fluid |
50255-9 |
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --3rd specimen fasting |
50408-4 |
Protein.abnormal band/Protein.total in Urine by Electrophoresis |
50559-4 |
Hemoglobin [Mass/volume] in Urine by Automated test strip |
50748-3 |
Alpha-2-Macroglobulin/Creatinine [Mass Ratio] in Urine |
50897-8 |
pH of 24 hour Urine by Test strip |
51043-8 |
CD123 blasts/Blasts in Bone marrow |
51191-5 |
Antimony [Mass/volume] in Body fluid |
51339-0 |
CD45 (Lymphs) cells/Cells in Cerebrospinal Fluid |
51488-5 |
Cortisol [Mass/volume] in Saliva (oral fluid) --6th specimen post XXX challenge |
51659-1 |
Hepatitis B virus surface Ag [Presence] in Body fluid |
51810-0 |
Coxiella burnetii phase 1 IgG Ab [Units/volume] in Serum by Immunoassay |
51994-2 |
Homovanillate/Creatinine [Mass Ratio] in Urine collected for unspecified duration |
52749-9 |
Etravirine [Susceptibility] by Genotype method |
52953-7 |
Cocaine [Moles/volume] in Urine |
53103-8 |
Decenoylcarnitine (C10:1) [Moles/volume] in Urine |
53251-5 |
Influenza virus B RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
53419-8 |
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --1st specimen post XXX challenge |
53565-8 |
Platelet aggregation in Platelet rich plasma by ADP induced 100 umol/mL |
53718-3 |
Acylglycines [Interpretation] in Urine Narrative |
5388-4 |
Toxoplasma gondii IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
54027-8 |
Lamin Ab [Presence] in Serum by Immunofluorescence |
54270-4 |
Glucose [Moles/volume] in Serum or Plasma --2.5 hour post dose ornithine alpha-ketoglutarate |
54430-4 |
Pooled platelets given [Volume] |
54749-7 |
Moving from seated to standing position during assessment period [CMS Assessment] |
55135-8 |
BCR-ABL1 kinase domain mutations found [Identifier] in Blood or Tissue by Targeted gene mutation analysis Nominal |
55379-2 |
Snowshoe hare virus IgM Ab [Presence] in Serum by Immunoassay |
55581-3 |
sulfaSALAzine [Moles/volume] in Serum or Plasma |
55746-2 |
How are you today: feeling low or worried |
55905-4 |
Alpha cortol [Mass/volume] in 24 hour Urine |
56137-3 |
LDL 2 [Moles/volume] in Serum or Plasma |
56290-0 |
House dust Greer IgG4 Ab [Mass/volume] in Serum |
56436-9 |
Zucchini IgG4 Ab [Mass/volume] in Serum |
56586-1 |
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
56734-7 |
Centromere protein B Ab [Presence] in Serum by Immunoblot |
56958-2 |
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
57231-3 |
Stage of most problematic pressure injury during assessment period [CMS Assessment] |
57393-1 |
CD11a cells/cells in Body fluid |
57541-5 |
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4th specimen post dose gonadotropin releasing hormone |
5769-5 |
Bacteria [#/area] in Urine sediment by Microscopy high power field |
57875-7 |
Cantaloupe IgG4 Ab [Mass/volume] in Serum |
58032-4 |
White Elm IgG Ab [Mass/volume] in Serum |
58384-9 |
6-Monoacetylmorphine (6-MAM)/Creatinine [Mass Ratio] in Urine |
58543-0 |
Corticotropin [Moles/volume] in Plasma --12 PM specimen |
5869-3 |
Parainfluenza virus 1 Ag [Presence] in Specimen by Immunofluorescence |
58849-1 |
Somatotropin [Mass/volume] in Serum or Plasma --15th specimen |
5900-6 |
Prothrombin Fragment 1.2 [Units/volume] in Serum or Plasma |
59214-7 |
Succinyladenosine/Creatinine [Molar ratio] in Urine |
59377-2 |
2-Methylacetoacetate/Creatinine [Molar ratio] in Urine |
59663-5 |
Diclofenac [Mass/volume] in Urine |
5982-4 |
Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis |
59976-1 |
traZODone [Moles/volume] in Gastric fluid |
60121-1 |
Pancuronium [Mass/volume] in Blood |
60276-3 |
oxyCODONE+oxyMORphone cutoff [Mass/volume] in Urine for Screen method |
60430-6 |
Hepatitis E virus genotype [Identifier] in Blood by NAA with probe detection |
60766-3 |
Gas delivery system inspiratory Isoflurane setting [VFr/PPres] |
61023-8 |
Enflurane gas delivered.total [Volume] in Reporting period from Gas delivery system |
61186-3 |
Spermatozoa thin midpiece/Spermatozoa in Semen |
61331-5 |
Beef IgE Ab/IgE total in Serum |
6198-6 |
Paper wasp IgE Ab [Units/volume] in Serum |
62435-3 |
Saint Louis encephalitis virus IgG Ab [Presence] in Body fluid by Immunoassay |
63092-1 |
Cheese cheddar type IgG Ab [Mass/volume] in Serum |
63238-0 |
Extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
63387-5 |
Elastase Ab [Presence] in Body fluid by Immunoassay |
6357-8 |
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection |
6447-7 |
Legionella pneumophila Ag [Presence] in Urine by Immunoassay |
65354-3 |
Proinsulin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
66114-0 |
Stomach Pathology biopsy report |
66752-7 |
Clot strength in Blood by Thromboelastography --after addition of heparinase |
67704-7 |
Feeding types |
6841-1 |
Grape IgE Ab [Units/volume] in Serum |
68963-8 |
Collection date and time of Specimen |
69148-5 |
XR Knee - left Views and Tunnel |
69305-1 |
XR Zygomatic arch 2 Views |
6968-2 |
Proteinase 3 Ab [Units/volume] in Serum |
69903-3 |
Service comment 76 |
7007-8 |
Dirithromycin [Susceptibility] by Gradient strip |
70265-4 |
Protein in pericardial fluid/Protein in serum |
70951-9 |
Interdialytic time [ESRD] |
71505-2 |
Date changed ownership Dialysis facility [ESRD] |
71695-1 |
Immature granulocytes/Leukocytes in Blood by Automated count |
71877-5 |
Hemoglobin A/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
7220-7 |
Horse Chestnut IgE Ab [Units/volume] in Serum |
7238-9 |
Cocklebur IgG Ab [Units/volume] in Serum |
72536-6 |
US Guidance for vascular sclerotherapy of Extremity veins - bilateral |
72729-7 |
7-Hydroxymitragynine/Creatinine [Mass Ratio] in Urine |
72884-0 |
CYP1A2 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
73038-2 |
Ciprofloxacin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
73185-1 |
Pseudoephedrine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
73330-3 |
Ipratropium induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
73477-2 |
Caspofungin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
73625-6 |
cefTAZidime+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
73796-5 |
Infant activity during preductal oxygen saturation measurement |
73950-8 |
JWH-250 (synthetic cannabinoid) [Presence] in Blood |
74105-8 |
Oxygen saturation Calculated from oxygen partial pressure in Mixed venous blood |
74328-6 |
MICA*030 IgG Ab [Presence] in Serum |
74487-0 |
P504S and p63 and Cytokeratin 903 Ag [Identifier] in Tissue by Immune stain |
74646-1 |
Methamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
74820-2 |
Plasma cells.centrocytes/Leukocytes in Blood by Manual count |
75-2 |
ceFAZolin [Susceptibility] by Minimum lethal concentration (MLC) |
75149-5 |
Deoxyguanosine [Moles/volume] in Cerebrospinal Fluid |
75327-7 |
Life expectancy [Time] Estimated |
75585-0 |
Comment on fetal Prader-Willi syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
75773-2 |
Goals, preferences, and priorities for medical treatment Narrative - Reported |
75997-7 |
Systolic blood pressure by Continuous non-invasive monitoring |
76147-8 |
Cefovecin [Susceptibility] by Minimum inhibitory concentration (MIC) |
7640-6 |
Pyrethrum triggered histamine release [Units/volume] in Blood |
76565-1 |
Left ventricular Cardiac output by US.2D+Calculated |
7681-0 |
Common Sagebrush IgE Ab [Units/volume] in Serum |
77138-6 |
Chloride [Moles/volume] in Serum, Plasma or Blood |
77343-2 |
Gamma globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration |
77601-3 |
Enhanced note |
77756-5 |
7-Aminoclonazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
77991-8 |
MMWR Week [CDC.PHIN] |
78352-2 |
Vaccenate (C18:1w7) [Entitic substance] in Red Blood Cells |
78789-5 |
Amoxapine [Mass/mass] in Hair |
78943-8 |
Cardiac procedure complications panel |
79180-6 |
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
79342-2 |
Carnitine biosynthesis intermediates pattern [Interpretation] in Urine Narrative |
79516-1 |
Octenedioate (C8:1) [Moles/volume] in Serum or Plasma |
79685-4 |
5,6-Dihydrouracil/Creatinine [Molar ratio] in Urine |
79830-6 |
Left eye Axis--W cycloplegia by Objective refraction |
79982-5 |
Left atrial End-systolic volume (by US.2D+Calculated by biplane area-length method)/Body surface area |
80127-4 |
Aluminum [Moles/volume] in Cerebrospinal Fluid |
80283-5 |
Murmur radiating to body location [Anatomy] by Auscultation |
80461-7 |
Dairy servings 24 hour Estimated |
80627-3 |
Coagulation factor X activated inhibitor [Mass/volume] in Platelet poor plasma |
80870-9 |
US for pregnancy limited |
81015-0 |
Arginine intake 24 hour Estimated |
81162-0 |
US Guidance for needle localization Breast - left and MG Views Breast specimen |
81364-2 |
Religious or cultural beliefs Narrative - Reported |
81586-0 |
NM Whole body Views W Y-90 ibritumomab tiuxetan IV |
8177-8 |
Cannabinoids [Presence] in Unknown substance |
81921-9 |
Lysine intake 24 hour Measured |
82143-9 |
Did you live with anyone who used illegal street drugs or who abused prescription medications |
8231-3 |
Phencyclidine [Mass/volume] in Meconium |
82506-7 |
Oligosaccharides pattern [Interpretation] in Fibroblast by Screen method Narrative |
82682-6 |
CT Clavicle - left WO contrast |
82854-1 |
Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
83033-1 |
XR Hip single view during surgery |
83234-5 |
Prior device use during assessment period [CMS Assessment] |
84900-0 |
Other nodule quadrant [Anatomy] in Prostate tumor |
85345-7 |
Dermal lymph-vascular invasion in Cancer specimen Qualitative by Light microscopy |
85569-2 |
Physical therapy - group minutes--week 2 [CMS Assessment] |
85776-3 |
Proteus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
86014-8 |
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
86160-9 |
Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum --2nd specimen |
86320-9 |
Zika virus neutralizing antibody [Presence] in Specimen by Neutralization test |
86518-8 |
Ebola virus RNA [Presence] in Blood by NAA with probe detection |
86704-4 |
Lawsonia intracellularis RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
86866-1 |
MDS v3.0 - RAI v1.17.2 - Urinary toileting program - NP, NQ, SP during assessment period [CMS Assessment] |
87056-8 |
Guidance for biopsy of Abdomen |
87216-8 |
Date on existing record to be modified or inactivated during assessment period [CMS Assessment] |
87418-0 |
Cytolethal distending toxin B Ab [Units/volume] in Serum by Immunoassay |
87615-1 |
Sulfate [Mass/mass] in Specimen |
87815-7 |
fentaNYL [Presence] in Saliva (oral fluid) by Screen method |
87979-1 |
Fungus identified in Pleural fluid by Culture |
88148-2 |
Microscopic observation [Identifier] in Genital specimen by Acid fast stain |
88330-6 |
Mobility - admission performance during 3 day assessment period [CMS Assessment] |
88546-7 |
Chlamydophila pneumoniae DNA [Presence] in Aspirate by NAA with probe detection |
88733-1 |
Mi-2 beta Ab [Units/volume] in Serum by Line blot |
89014-5 |
Oxygen was used for preoxygenation |
89315-6 |
CD4+CD25+CD45RA+CD127Low+ cells [#/volume] in Blood |
89533-4 |
SCL-70 extractable nuclear Ab [Presence] in Cerebrospinal Fluid by Line blot |
89851-0 |
CTA Unspecified body region limited |
90104-1 |
Emergency operations center standard operating procedure name |
90442-5 |
Coxiella burnetii aroE gene [Presence] in Tissue by NAA with non-probe detection |
90781-6 |
N,N'-dimethylarginine [Mass/volume] in Serum or Plasma |
91017-4 |
Regional hospitals closed due to event or incident/Total regional hospitals |
91542-1 |
Myelin oligodendrocyte glycoprotein Ab [Titer] in Cerebrospinal Fluid by Cell binding immunofluorescent assay |
91795-5 |
Respiratory syncytial virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
92045-4 |
Name of Donor |
92555-2 |
Biophysical agent plan to use |
92795-4 |
Candida guilliermondii DNA [Presence] by NAA with probe detection in Positive blood culture |
92995-0 |
THBD gene full mutation analysis in Blood or Tissue by Sequencing |
93229-3 |
LCDS v5.00 - Patient demographic information - admission during assessment period [CMS Assessment] |
93422-4 |
Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Cerebrospinal Fluid by Cell binding immunofluorescent assay |
93656-7 |
Left ventricular Stroke volume by US.2D.A4C+Calculated by single plane method of disks |
93835-7 |
Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
94025-4 |
Anxiety severity |
94214-4 |
PRKAR1A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
94396-9 |
Influenza virus A H1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
94614-5 |
Bovine parainfluenza virus 3 RNA [Cycle Threshold #] in Specimen by NAA with probe detection |
94827-3 |
Epstein Barr virus DNA [Presence] in Amniotic fluid by NAA with probe detection |
94982-6 |
Placing telephone call - usual functional ability during assessment period [CMS Assessment] |
95163-2 |
Infectious bronchitis virus Ab/Positive control in Serum by Immunoassay |
95326-5 |
Corrective lens Spherical equivalent Calculated |
95496-6 |
Other substances that you have had a strong desire or urge to use in the past 3 months [NIDA] |
95666-4 |
Tahyna virus IgG Ab [Presence] in Specimen by Immunoassay |
95842-1 |
Lymphocytes/Leukocytes in Sputum by Manual count |
96060-9 |
Hematologic cancer |
96271-2 |
DNA mismatch repair protein Msh3 Ag [Presence] in Cancer specimen by Immune stain |
9645-3 |
Metanephrine/Creatinine [Mass Ratio] in Urine |
96618-4 |
HLA-B [Type] in Donor by High resolution |
96790-1 |
SOFA Total Score |
96968-3 |
TNFAIP3 gene mutations found [Identifier] in Blood or Tissue by Targeted gene mutation analysis Nominal |
97130-9 |
How helpful has playing games with family members been as a coping strategy during the COVID-19 outbreak |
97281-0 |
Morphine Free [Presence] in Cord tissue by Confirmatory method |
97430-3 |
XR Finger third - right AP |
97598-7 |
CD3-CD16+CD56+ (Natural killer) cells/Lymphocytes in Lower respiratory specimen by Flow cytometry (FC) |
97818-9 |
Blood product volume and/or cell saver |
97992-2 |
Herpes virus 6 IgM Ab [Presence] in Serum by Immunofluorescence |
9816-0 |
Actinomyces sp identified in Specimen by Organism specific culture |
98316-3 |
XR Knee - bilateral Single view W valgus stress |
98469-0 |
Right eye Horizontal prism - in near by Phoropter |
98698-4 |
Sensory nerve action potential amplitude Nerve |
98844-4 |
Right eye Vertical prism - down for near fixation disparity by Phoropter |
99008-5 |
Leptospira interrogans sv Djasiman Ab [Titer] in Serum by Agglutination |
99176-0 |
OASIS E - Special Treatment, Procedures, and Programs - transfer to an inpatient facility during assessment period [CMS Assessment] |
99365-9 |
Sheep milk IgG Ab [Mass/volume] in Serum |
99526-6 |
Thickness [Length] of Right ventricle |
99691-8 |
Pacemaker Ventricular sensitivity setting |
99847-6 |
Frequency of producing verbal messages with appropriate form in low demand situations |
End of sample. 500 of 85,065 codes are listed above; $expand the set against the terminology service for all of them.